BMJ Open (Apr 2022)

Evidence for overuse of cardiovascular healthcare services in high-income countries: protocol for a systematic review and meta-analysis

  • Carl van Walraven,
  • Henry Thomas Stelfox,
  • Derek J Roberts,
  • Daniel Niven,
  • Mamas Mamas,
  • Ian D Graham,
  • Daniel I McIsaac,
  • Jeremy Grimshaw,
  • Sudhir K Nagpal,
  • Risa Shorr,
  • Emma E Sypes

DOI
https://doi.org/10.1136/bmjopen-2021-053920
Journal volume & issue
Vol. 12, no. 4

Abstract

Read online

Introduction Overuse of cardiovascular healthcare services, defined as the provision of low-value (ineffective, harmful, cost-ineffective) tests, medications and procedures, may be common and associated with increased patient harm and health system inefficiencies and costs. We seek to systematically review the evidence for overuse of different cardiovascular healthcare services in high-income countries.Methods and analysis We will search MEDLINE, EMBASE and Evidence-Based Medicine Reviews from 2010 onwards. Two investigators will independently review titles and abstracts and full-text studies. We will include published English-language studies conducted in high-income countries that enrolled adults (mean/median age ≥18 years) and reported the incidence or prevalence of overuse of cardiovascular tests, medications or procedures; adjusted risk factors for overuse; or adjusted associations between overuse and outcomes (reported estimates of morbidity, mortality, costs or lengths of hospital stay). Acceptable methods of defining low-value care will include literature review and multidisciplinary iterative panel processes, healthcare services with reproducible evidence of a lack of benefit or harm, or clinical practice guideline or Choosing Wisely recommendations. Two investigators will independently extract data and evaluate study risk of bias in duplicate. We will calculate summary estimates of the incidence and prevalence of overuse of different cardiovascular healthcare services across studies unstratified and stratified by country; method of defining low-value care; the percentage of included females, different races, and those with low and high socioeconomic status or cardiovascular risk; and study risks of bias using random-effects models. We will also calculate pooled estimates of adjusted risk factors for overuse and adjusted associations between overuse and outcomes overall and stratified by country using random-effects models. We will use the Grading of Recommendations, Assessment, Development and Evaluation to determine certainty in estimates.Ethics and dissemination No ethics approval is required for this study as it deals with published data. Results will be presented at meetings and published in a peer-reviewed journal.PROSPERO registration number CRD42021257490.